prasad leaving CBER. huge.
Company: uniQure
Tags: strategy, launch, leadership
gene therapy and rare disease took the worst of his tenure. unpredictable bar, surprise CRLs, moving goalposts. UniQure up 36% is not an overreaction. certainty is what this market needed. trajectory changed today
11 upvotes · 5 comments